The Chinese University of Hong Kong
Hong Kong
NCT Number: NCT05927207
The objective of this study is to conduct a pilot randomised controlled trial (RCT) evaluating the feasibility, acceptability, and preliminary efficacy of a 6-week mobile app-based intervention in empowering and supporting Chinese parents of autism spectrum disorder (ASD) children through knowledge and skills transfer and mindfulness training. The investigators hypothesise that the app will be feasible and acceptable, and that there will be a greater reduction in parental stress and mood symptoms, and improvement of mindfulness attitude and parenting competence in parents with ASD children after the 6-week app-based intervention than the waitlist controls.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Hong Kong
Parents of autism spectrum disorder (ASD) children are often stressed about challenges in raising their children with multifaceted needs, and their stress could undermine the child's development. With the ever-increasing demand in clinical services and disruptions by the coronavirus pandemic (COVID-19), the aim of the study is to investigate the clinical efficacy of a mobile app-based intervention in reducing stress and mood symptoms, and enhancing mindfulness and competence in parents of children with ASD. The 6-week mobile app-based intervention programme, TRIP, is a structured course of mindfulness training, and knowledge and skills transfer of parenting ASD children with specific content personalised to the participant's needs, which was developed as an accessible and scalable primary-level care platform to improve the well-being of parents.
In this study, a pilot randomized waitlist-controlled trial will be conducted. 40 parents of ASD children who are ≤12 years of age and either 1. waiting for, or 2. actively receiving treatment from a regional children psychiatric specialist clinic will be recruited. Parents will be randomized into an immediate intervention arm and a waitlist arm. Feasibility, acceptability, as well as preliminary efficacy of the app will be investigated. Parental stress level, mood symptoms, competence, and level of mindfulness will be measured before, immediately after, and 2 months after the intervention with self-reported questionnaires.
The results of the proposed study will provide insights with regards to the design and implementation of the main randomised controlled trial (RCT), contributing to the generation of evidence to the real-life efficacy of a mobile app-based intervention service model to support parents of children with ASD in the era of digital mental health. As the impact of mental well-being of parents extends beyond the parents themselves, effective management of the elevated level of parental stress in ASD families is beneficial to the family functioning and long-term development of the child. The solid evidence from the main trial can also inform clinicians and service-users in choosing the evidence-based intervention suitable to their context, among the range of commercially available products with claimed efficacy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TRIP is a mobile app-based intervention for supporting and empowering parents of children with autism spectrum disorder (ASD), comprises of a 6-week structured training on mindfulness and educational modules on ASD parenting skills.
Time frame: Immediately post-intervention
Response rates during recruitment
Time frame: Immediately post-intervention
Dropout rates from pre-intervention to immediately post-intervention
Time frame: 2 months post-intervention
Dropout rates from pre-intervention to 2-month post intervention
Time frame: Immediately post-intervention
Platform on which the app is accessed from, Apple's iPhone operating system (iOS) or Android, will be recorded
Time frame: Immediately post-intervention
Whether the app is used on weekdays or weekends will be recorded
Time frame: Immediately post-intervention
Time of day of use (in 4-hour blocks) will be recorded
Time frame: Immediately post-intervention
Number of days with logins within the 6-week intervention period
Time frame: Immediately post-intervention
Time spent in app per login within the 6-week intervention period
Time frame: Immediately post-intervention
Number of unique components completed within the 6-week intervention period
Time frame: Immediately post-intervention
Number of core session completed within the 6-week intervention period
Time frame: Immediately post-intervention
Number of optional session completed within the 6-week intervention period
Time frame: Immediately post-intervention
Measured by the 10-item System Usability Scale (SUS; Brooke, 1996) for assessing the usability of products and apps. SUS scores have a range of 0 to 100, with a higher score means greater app usability.
Time frame: Immediately post-intervention
Measured by the 20-item Mobile Application Rating Scale - User Version (uMARS; Stoyanov et al., 2016) that measures engagement, functionality, aesthetics, information quality of mobile health apps. Scores range from 1 to 5, with a higher score indicating higher app quality.
Time frame: Pre-intervention
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
Time frame: Immediately post-intervention
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
Time frame: 2-months post-intervention
Measured by the 7-item Generalised Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) for anxiety symptoms. GAD-7 scores range from 0 to 21, higher scores indicating greater levels of anxiety symptoms.
Time frame: Pre-intervention
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
Time frame: Immediately post-intervention
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
Time frame: 2-months post-intervention
Measured by the 9-item Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) for depressive symptoms. PHQ-9 scores range from 0 to 27, higher scores indicating greater levels of depressive symptoms.
Time frame: Pre-intervention
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.
Time frame: Immediately post-intervention
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.
Time frame: 2-months post-intervention
Measured by the 36-item Parenting Stress Index-Short Form (PSI-SF), considering three domains of parenting distress, difficult child, and parent-child dysfunctional interaction. Scores range from 36 to 180, with higher scores indicating greater levels of stress.
Time frame: Pre-intervention
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
Time frame: Immediately post-intervention
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman, 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
Time frame: 2-months post-intervention
Measured by the 17-item Parenting Sense of Competence scale (PSOC; Gibaud-Wallston & Wandersman; 1978). Scores ranges between 17 to 102, with higher scores indicating a higher parenting sense of competency.
Time frame: Pre-intervention
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
Time frame: Immediately post-intervention
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
Time frame: 2-months post-intervention
Measured by the 6-item Parenting Efficacy subscale of the Parenting Self-Agency Measure (Dumka et al., 1996). Scores ranges between 6-42, with higher scores indicating higher levels of parenting efficacy.
Chinese University of Hong Kong
Other
Pilot Testing of a Mobile Phone App-based Intervention for Supporting and Empowering Parents of Children With Autism Spectrum Disorder (ASD): a Mixed-method Study of Feasibility, Acceptability, and Preliminary Efficacy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05927116
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Hong Kong
View Trial DetailsNCT03880383
Autism Spectrum Disorder, Child Development Disorder
Vancouver, British Columbia, Canada
View Trial DetailsNCT05852548
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Melbourne, Victoria, Australia
View Trial DetailsNCT03071120
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Madison, Wisconsin, United States
View Trial Details